Open AccessNew opportunities for the combined therapy of allergic rhinitis in real clinical practice
Author(s) -
Evgeniya V. Nazarova,
Назарова Евгения Валерьевна
Publication year - 2019
Publication title -
rossijskij allergologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2686-682X
pISSN - 1810-8830
DOI - 10.36691/rja34
Subject(s) - medicine , concomitant , betamethasone , nasal congestion , incidence (geometry) , clinical practice , dermatology , anesthesia , nose , surgery , physical therapy , physics , optics
This paper assesses the efficacy of the original combined medication Allergoferon® beta (betamethasone + interferon alpha-2b) in real clinical practice among patients with seasonal allergic rhinitis (AR). The research program results demonstrated a good efficacy of the given medication: there were a decrease in nasal congestion as well as restoration of nasal breathing and in patients with concomitant allergic conjunctivitis - a reduction in the severity of eye symptoms. A low incidence of side effects was observed. It was shown that Allergoferon® beta can be recommended as monotherapy for patients with mild and moderate AR and in complex therapy for patients with severe AR.